Cantor Fitzgerald Expects Increased Earnings for CVS Health

CVS Health Co. (NYSE:CVS) – Equities research analysts at Cantor Fitzgerald boosted their FY2025 earnings per share estimates for shares of CVS Health in a research note issued on Thursday, February 13th. Cantor Fitzgerald analyst S. James now anticipates that the pharmacy operator will earn $5.86 per share for the year, up from their previous forecast of $5.71. Cantor Fitzgerald currently has a “Overweight” rating on the stock. The consensus estimate for CVS Health’s current full-year earnings is $5.14 per share.

CVS has been the topic of several other reports. Evercore ISI increased their price target on CVS Health from $60.00 to $65.00 and gave the company an “outperform” rating in a report on Monday, January 27th. Wells Fargo & Company increased their price target on CVS Health from $68.00 to $73.00 and gave the company an “overweight” rating in a report on Thursday. Leerink Partners raised CVS Health from a “market perform” rating to an “outperform” rating and increased their price target for the company from $55.00 to $75.00 in a report on Thursday. TD Cowen increased their price target on CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a report on Monday, November 25th. Finally, Wolfe Research increased their price target on CVS Health from 67.00 to 70.00 and gave the company an “overweight” rating in a report on Tuesday. Four analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, CVS Health presently has an average rating of “Moderate Buy” and a consensus target price of $70.28.

CVS Health Stock Performance

CVS stock opened at $66.35 on Friday. The stock has a market capitalization of $83.49 billion, a PE ratio of 16.84, a price-to-earnings-growth ratio of 0.60 and a beta of 0.61. CVS Health has a 12-month low of $43.56 and a 12-month high of $80.75. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The stock’s 50 day simple moving average is $50.71 and its 200 day simple moving average is $55.94.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 10.72% and a net margin of 1.36%.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in CVS. AMF Tjanstepension AB grew its position in shares of CVS Health by 124.1% during the third quarter. AMF Tjanstepension AB now owns 61,744 shares of the pharmacy operator’s stock valued at $3,882,000 after purchasing an additional 34,198 shares in the last quarter. Exchange Traded Concepts LLC grew its position in shares of CVS Health by 61.9% during the third quarter. Exchange Traded Concepts LLC now owns 14,853 shares of the pharmacy operator’s stock valued at $934,000 after purchasing an additional 5,679 shares in the last quarter. Procyon Advisors LLC bought a new position in shares of CVS Health in the 3rd quarter valued at about $202,000. Creative Planning lifted its holdings in shares of CVS Health by 23.5% in the 3rd quarter. Creative Planning now owns 250,891 shares of the pharmacy operator’s stock valued at $15,776,000 after acquiring an additional 47,737 shares during the last quarter. Finally, Sumitomo Life Insurance Co. lifted its holdings in shares of CVS Health by 3.0% in the 3rd quarter. Sumitomo Life Insurance Co. now owns 17,692 shares of the pharmacy operator’s stock valued at $1,112,000 after acquiring an additional 516 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were given a dividend of $0.665 per share. The ex-dividend date was Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.01%. CVS Health’s payout ratio is 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.